Mr. Tuv is currently Investment Director at early stage life science investment company Radforsk with a focus on immunotherapies and precision medicines. He is an experienced investment and business development professional with broad experience from the health care and biotech industry covering C-level positions, strategy and business development, research collaborations, licensing deals, M&As and IPOs. He has extensive experience with establishing and developing early stage biotech companies, as well as fundraising and private placements as an investor. Mr. Tuv has also been heavily involved in the development of a sound Norwegian Biotech Cluster through initiatives as the Oslo Cancer Cluster and as one of the founders of Oslo Cancer Cluster Incubator.
He is currently an Executive Chairman of the Board of Zelluna Immunotherapy, Chairman of Oncolmmunity, Non-executive Director Vaccibody, Non-executive Director Nextera, Non-executive Director Oslo Cancer Cluster Incubator, and member of the Nomination Committee of Targovax ASA.